2010
DOI: 10.1016/s0028-3843(14)60133-x
|View full text |Cite
|
Sign up to set email alerts
|

Nowe wytyczne dotyczące leczenia bólu neuropatycznego

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
5
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 34 publications
0
5
0
Order By: Relevance
“…According to estimates, about 15 million people experience a stroke each year, including 5 million deaths and another 5 million disabilities [3,5,6,7].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…According to estimates, about 15 million people experience a stroke each year, including 5 million deaths and another 5 million disabilities [3,5,6,7].…”
Section: Introductionmentioning
confidence: 99%
“…It is a life-threatening condition, which is an absolute indication for urgent hospitalization (preferably in a specialized stroke unit). Etiologically, stroke is divided into: ischemic strokecaused by the cessation of blood supply to a part of the brain (80% -90% of stroke cases) due to cerebral artery occlusion, and hemorrhagic stroke -caused by a rupture of the cerebral artery wall and blood escaping from the vessel (20-10% of cases) [1,2,7]. The american outstanding neurologist C. Miller Fisher discovered TIA (transient ischemic attack).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The same lesion or disease may induce the development of neuropathic, somatic or even psychogenic pain. 2 The four criteria for grading NP diagnosis are as follows: I. Neuro-anatomical related pain. II.…”
Section: Introductionmentioning
confidence: 99%
“…They include recommendations of expert groups commissioned by international medical associations, such as the International Association for the Study of Pain (IASP) and the European Federation of Neurological Societies (EFNS), as well as recommendations of national research associations in countries such as Australia, France, Canada and South Africa. Some of these recommendations have been presented previously to Polish physicians [1,2]. Differences related to the health care system and drug availability on the Polish pharmaceutical market necessitate adapting the recommendations to Poland-specific conditions.…”
Section: Introductionmentioning
confidence: 99%